Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Enara Health Accelerates National Telehealth Rollout of Clinical Weight Loss Program to Combat COVID-19 Effects


By expanding our program through progressive, like-minded clinics around the country, particularly in this time of crisis, we expect to dramatically improve lives while also decreasing the devastating stigma attached to obesity today.

Enara Health, a technology-powered personalized weight loss program focused on sustainable results, today announced that it is expanding telehealth availability of its program to all residents in California, Texas and Illinois. This rollout represents an earlier-than-planned first stage of a national rollout of the Enara Health platform, a clinical weight loss program that takes a multi-faceted approach to obesity treatment.

The intent of this accelerated telehealth rollout is to give more Americans access to proven, physician-guided weight loss support during the COVID-19 pandemic as a key means of boosting patients’ health and immune systems. Via Enara Health’s unique telehealth interface, program participants will be able to connect with a team of doctors, dietitians and exercise specialists from their mobile phones and computers.

“Numerous studies have shown that nutrition, activity and stress management play a vital role in our immune defense against respiratory viruses, and our goal is to help Americans achieve optimal health to fight the virus,” said Dr. Rami Bailony, Co-Founder and CEO of Enara Health. “Rather than viewing healthy eating, exercise and stress relief as something to be dealt with after this acute crisis is over, we need to reframe these practices as important prevention strategies.”

Unlike most other weight loss programs that focus solely on diet or lifestyle modification, the Enara Health platform combines physician interactions, lifestyle evaluations, diet consultations and medication through a unique digital health platform. This precision medicine approach is designed to maximize results through personalized, data-driven recommendations.

Participants in the Enara Health precision weight loss program lose an average of 12.40% of their weight at 6 months and 13.99% at 18 months, a significant improvement over other digital health programs and on par with results seen in bariatric surgery patients.

The telehealth rollout of the Enara Health program beyond its first clinic in San Mateo, Calif., is possible due to newly forged relationships with specialized partner clinics in Texas (WellHealth locations in the Dallas-Fort Worth area) and Illinois (the Center for Adult and Pediatric Wellness in Orland Park). Once the COVID-19 pandemic recedes, local patients will also gain access to in-office physician consultations through these clinics.

“We have spent the past four years establishing, evaluating and fine-tuning Enara Health’s clinical approach to weight loss at our clinic in San Mateo, Calif.,” said Dr. Rami Bailony, Co-Founder and CEO of Enara Health. “The results we’re now achieving have the potential to redefine obesity treatment as we know it. By expanding our program through progressive, like-minded clinics around the country, particularly in this time of crisis, we expect to dramatically improve lives while also decreasing the devastating stigma attached to obesity today.”

Residents in California, Texas and Illinois can now enroll in the Enara Health program. Learn more at http://www.enarahealth.com.

About Enara Health

Enara Health is building a data-driven platform and network to scale obesity treatment. Based in San Mateo, Calif., and operating since March 2015, Enara Health offers unique hybrid digital and in-person weight loss programs based on precision medicine. By combining mobile technology with health care visits and providing patients with personalized physician-driven medical weight loss programs, Enara Health routinely helps patients lose—and keep off—more than 15% of their baseline weight, which is far greater than the results seen with other e-health and m-health interventions. Learn more at http://www.enarahealth.com.

Share article on social media or email:

Donating To Hospitals, Young Entrepreneurs’ Hand Sanitizer Sweeps Internet By Storm


Furthermore, on top of selling thousands of bottles, Z Skin Cosmetics has been donating bottles weekly to hospitals and healthcare workers in need

In the wake of the current health crisis, things like medical masks, disinfectants, and hand sanitizers are scarce. But Ryan Zamo, the 30-year-old entrepreneur behind Z Skin Cosmetics, has astonished customers across the globe with his ability to maintain stock of his Simply Sanitizer even while selling thousands of bottles weekly. Furthermore, on top of the massive increase in sales Z Skin Cosmetics has been donating dozens of bottles weekly to hospitals and healthcare workers in need, Zamo commented, “We never sold a lot of our sanitizer before the pandemic, but because we’ve become so blessed with this windfall of success, the least we can do is donate to those in need.”

It seems a bit suspect that a small business can keep up with an influx of orders, while in contrast, large manufacturing plants seem to lag. We asked Zamo what his secret is to maintaining supply; he told us, “Well, we are a handcrafted organic skincare brand. That means we are constantly disinfecting everything and maintaining a sterile environment. Therefore, we always have ample stock of the ingredients needed to make our sanitizer.” But besides having the ingredients, there is also one more aspect to his ability to keep up with the demand; he added, “You can have all the ingredients in the world, but that doesn’t necessarily mean you’ll be able to fill big orders. It’s because we make every product to order, which means a few things. First, since we make our products, we don’t have any “stock items,” meaning nothing is just sitting around waiting to be sold. And second, that means we have no inventory, so we make the products as the orders are placed.”

Furthermore, according to the business owner, over 90% of original customers have come back and ordered more units from him, he commented, “Our sanitizer is a sanitizer lotion, it gets the job done, but it doesn’t dry out your hands. It moisturizes your hands too, and with the terrible weather conditions, it’s a combination of two things everyone needs right now.”

With the ability to maintain stock and keep orders going out, Z Skin Cosmetics has been on the top of its game. While other companies are back-ordered and unable to fill large orders, Zamo is busy working hard to get his customers their hand sanitizers within 2-3 days. Between major businesses ordering from Z Skin Cosmetics as well as a flood of global consumers in need of hand sanitizer, the entrepreneur seems to be keeping up well with the spike in orders.

For more information on their product, visit:

https://zskincosmetics.com/collections/complete-systems/products/simply-sanitizer-6-oz

For more information on the company, visit:

https://zskincosmetics.com/pages/who-and-how-z-skin-came-to-be

Contact:

Michael Nore

Nore.Marketing@ZskinCosmetics.Com

Share article on social media or email:

SmartMouth Dry Mouth Products Offer Relief For Oral Cancer Patients


SmartMouth Dry Mouth Mints with Zinc

SmartMouth Dry Mouth Mints with Zinc

SmartMouth’s resident dentist and ADA member Dr. Elizabeth Clary asserts, “Dry Mouth Activated Oral Rinse provides relief from the symptoms and discomfort of dry mouth, it moisturizes and soothes oral irritation, and it lubricates oral dryness.”

More than 53,000 Americans will be diagnosed with oral cancer in 2020.

In honor of Oral Cancer Awareness Month this April, SmartMouth has partnered with Mediaplanet to help bring awareness to this disease through their Oral Health campaign, which launched last week.

In this month’s issue entitled Oral Health, Emmy Award-winning voice actor, author, and singer Rob Paulsen describes his journey through his diagnosis, treatment, and recovery from throat cancer, and how he adjusted to his “new normal.” As the spokesperson for Head and Neck Cancer Alliance’s Oral, Head, and Neck Cancer Awareness Program, Paulsen stresses the importance of early detection and prevention, and empathizes with patients and survivors who have struggled with the disease.

Those suffering from oral cancer endure harsh side effects, from difficulty swallowing to loss of their voice. One of the most common ongoing side effects of many cancer treatments is dry mouth, which is caused by the destruction of the salivary glands.

SmartMouth offers two complimentary solutions for those suffering from dry mouth.

SmartMouth’s resident dentist and ADA member Dr. Elizabeth Clary asserts, “Dry Mouth Activated Oral Rinse provides relief from the symptoms and discomfort of dry mouth, it moisturizes and soothes oral irritation, and it lubricates oral dryness.”

In addition to the Dry Mouth Activated Oral Rinse, SmartMouth recently launched dual-action Dry Mouth Mints, which contain Zinc for oral health and Xylitol, a saliva stimulant. The convenient pouch design fits easily in your pocket for on-the-go dry mouth relief.

About SmartMouth Oral Health Laboratories

SmartMouth Oral Health Laboratories manufactures and markets SmartMouth branded mouthwash, toothpaste and mints through national retailers and online. Headquartered in St. Louis, Missouri, SmartMouth has been working to eliminate and prevent bad breath since 1993.

For a special offer on Dry Mouth products, please visit https://www.smartmouth.com/dmoffer.

The Oral Health campaign was distributed by Mediaplanet through USA TODAY on March, 31 2020 and is published online here:

https://issuu.com/mediaplanet_usa/docs/oral_health_final_boston

https://www.futureofpersonalhealth.com/oral-health/head-and-neck-cancer-means-a-difficult-new-normal-for-many-survivors/

Share article on social media or email:

Mindray North America Deploys Key Strategies to Support U.S. Healthcare Response to Coronavirus


Mindray North America

Mindray North America deploys key strategies to support
U.S. healthcare response to coronavirus

Mindray shares a social responsibility to actively and continuously participate in the fight against coronavirus; more specifically, we see our role in this healthcare crisis tying directly back to our mission – to make the most advanced healthcare technology attainable to all.

As a leading developer and manufacturer of medical device solutions and technologies used in healthcare facilities around the globe, Mindray recognizes the extraordinary stress the coronavirus pandemic is creating within our nation’s healthcare system. With its North American headquarters in Mahwah, New Jersey, adjacent to the epicenter of the pandemic, the Mindray North America team is experiencing the ravaging effects of the virus firsthand, through the eyes of our customers, our trusted partners and our dedicated employees and their families.

“The increased pressure being put on our nation’s healthcare infrastructure is unprecedented, manifesting itself in many ways,” said Mindray North America President, Wayne Quinn. “As a manufacturer dedicated solely to the medical industry, Mindray shares a social responsibility to actively and continuously participate in the fight against coronavirus; more specifically, we see our role in this healthcare crisis tying directly back to our mission – to make the most advanced healthcare technology attainable to all, and we continue to shift our organizational focus toward doing just this.”

Given the extreme set of circumstances surrounding the coronavirus pandemic and the urgent need for ventilators, Mindray North America has put into action several key strategies to enable our customers to maximize the use of Mindray systems currently in place. The North American team has diligently worked with the US Food and Drug Administration (FDA) to gain clearance from the agency for conversion and off label use of Mindray A-Series anesthesia delivery systems as continuous ventilators. This immediately increases availability of critical mechanical ventilation across the country. In addition, we have also published procedures for switching the drive gas (utilized to fill the bellows required for mechanical ventilation) in the anesthesia/ventilator from oxygen to compressed air. The ability to implement this conversion helps healthcare providers to preserve oxygen, which is also in short supply, for use in directly treating patients.

Earlier this week, via an unprecedented global team effort, we not only successfully secured Emergency Use Authorization (EUA) from the FDA allowing import of our ventilators (which previously were not cleared for sale in the US), but also procured a defined supply of standalone ventilators, to be immediately shipped and distributed to key hospitals in New York City which are presently in dire need.

Finally, in anticipation of the increasing demand for vital signs, multi-parameter monitors (bedside and portable) and centralized monitoring systems, we have proactively ramped up production and supply of these products, while at the same time implementing procedures for simplified, rapid deployment of these systems. This pre-emptive move is enabling accelerated set up of ad hoc, ancillary treatment areas, while minimizing the need for onsite support and installation time.

The entire Mindray North America team remains fully committed to aiding our nation’s response to this pandemic illness. As an essential business, we continue to work, each and every day supporting healthcare providers across the nation as they serve on the front lines, defending the health of our nation, one patient at a time.

About Mindray

Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

Share article on social media or email:

The National Infertility Association to Observe National Infertility Awareness Week


News Image

People with infertility and those struggling to build a family need support more than ever.

RESOLVE: The National Infertility Association will recognize National Infertility Awareness Week®, April 19 through April 25, 2020. The movement brings together millions of Americans who want to remove the stigmas and barriers that stand in the way of building families. RESOLVE will rally the infertility community to raise awareness about the significant lack of access to family building options and emotional support for millions of women and men struggling to build a family.

“RESOLVE is committed to hosting the 2020 National Infertility Awareness Week. With so many live events cancelled because of COVID-19, people with infertility and those struggling to build a family need support more than ever,” said Barbara Collura, RESOLVE’s President/CEO. “Let’s use NIAW to raise our voices, talk about the issues facing this community and make sure we continue to support those most in need.”

Throughout NIAW, members of the infertility community will take to the internet to share their stories and lead the conversation about challenges to family building and methods of resolution. Through national media, social media, and fundraising, the infertility community will take action to increase awareness of infertility in order to remove stigmas and improve access to family building options.

RESOLVE’s National Infertility Awareness Week 2020 is supported by its NIAW Partners: EMD Serono, Ferring Pharmaceuticals, First Response, Guerbet, Merck, and ORM Fertility.

NIAW became a federally recognized health observance by the Department of Health and Human Services in 2010. RESOLVE can provide experts for interviews on all aspects of infertility, as well as personal patient stories from women and men living with infertility. Find out more about NIAW at infertilityawareness.org.

About RESOLVE: The National Infertility Association: Established in 1974, RESOLVE: The National Infertility Association is a non-profit organization with the only established, nationwide network mandated to promote reproductive health and to ensure equal access to all family building options for men and women experiencing infertility or other reproductive disorders. One in eight U.S. couples of childbearing age has trouble conceiving or carrying a pregnancy to term. RESOLVE addresses this public health issue by providing community to these women and men, connecting them with others who can help, empowering them to find resolution and giving voice to their demands for access to all family building options. For more information, visit http://www.RESOLVE.org.

Share article on social media or email:

Virginia Removes Barriers to Students’ Sunscreen Use with ASDSA’s SUNucate Model Legislation


ASDSA SUNucate logo

I congratulate Virginia for adopting this important, common sense legislation that will help protect students from overexposure to the sun, which is essential to preventing skin cancer later in life.

Virginia’s public school students will now be able to possess and use sunscreen on school buses, school property and at school-sponsored events without a note thanks to the passage of Senate Bill 44, signed by Governor Ralph Northam on March 31.

Virginia is the 25th state to incorporate policies from model legislation developed by the American Society for Dermatologic Surgery Association (ASDSA). The legislation is a key part of the SUNucate initiative that addresses barriers to sunscreen use in school and camps and promotes sun-safe behavior. ASDSA advocated for this legislation together with the 60+ member SUNucate Coalition, including the Medical Society of Virginia and the Virginia Dermatology Society (VDS).

“I congratulate Virginia for adopting this important, common sense legislation that will help protect students from overexposure to the sun, which is essential to preventing skin cancer later in life,” said ASDSA President Marc D. Brown, MD. “ASDSA looks forward to working with partners in the states that have not yet passed SUNucate policies to advocate for the removal of barriers to sunscreen use in schools that still exist.”

“VDS was pleased to support this critical effort in Virginia,” said ASDSA member and VDS Board member Farhaad Riyaz, MD. “Virginia’s students will now have the opportunity to learn sun-safe habits from an early age.”

The need for such legislation arose after concerns were raised by dermatologists and reports in the national media about broad “medication bans” that are in place in schools across the country requiring students to have a note or prescription from a physician in order to have these medications. Sunscreens are regulated as over-the-counter drugs under the Federal Food, Drug and Cosmetic Act, making them subject to these bans. Although these policies are meant to protect children, they also hinder them from accessing sunscreen during outdoor school activities and put them at risk of damaging sun exposure.

To learn more about SUNucate, visit http://asds.net/SUNucate.

# # #

About ASDSA

With a membership of 6,400+ physicians, ASDSA is a 501(c)(6) association dedicated to education and advocacy on behalf of dermatologic surgeons and their patients. For more information, visit http://asds.net/ASDSA

Follow @ASDSAdvocacy on Facebook, Twitter and Instagram!

Share article on social media or email:



BioCT to Host Virtual Panel of Connecticut Companies Working on COVID-19


News Image

As the world eagerly awaits a vaccine to COVID-19, we greatly appreciate the efforts of our Connecticut bioscience companies to develop a solution.

WHAT: Connecticut companies that are working on COVID-19 will participate in a virtual (online) panel discussion, open to the public, on the current state of therapeutic and vaccine pipelines, new developments and future plans.

The panel is presented by BioCT and hosted by AdvanceCT. “As the world eagerly awaits a vaccine to COVID-19, we greatly appreciate the efforts of our Connecticut bioscience companies to develop a solution,” Dawn Hocevar, BioCT president and CEO, said. “We look forward to hearing their insights during this discussion.”

WHEN:        

Wednesday, April 8, 2020

10:30 AM – 12:00 PM EDT

WHO:        

Panelists:

Moderator:

Mostafa Analoui, PhD, Executive Director of Venture Development, Office of the Vice President for Research & Technology Incubation Program (TIP), UConn

WHERE:    Register here.

FORMAT: Panel discussion (with audio and video of panelists and moderator) followed by a Q&A during which registrants may pose questions through virtual chat.     

FEE: Free

INVITEES: Open to the public

Share article on social media or email:

eClinical Solutions Delivers elluminate COVID-19 Clinical Trial Analytics


“We developed elluminate COVID-19 Analytics based on feedback from clients looking to expand their use of elluminate for immediate insights on the pandemic’s impact with their ongoing clinical trials,” said Raj Indupuri, CEO of eClinical Solutions.

eClinical Solutions LLC, a leading global provider of cloud-based enterprise software and software-driven clinical data services, today announced an addition to its elluminate® platform, COVID-19 Analytics. These analytics help sponsors proactively manage the risks of COVID-19 for their ongoing clinical trials. The visualizations provide real-time trial information based on numerous data sources, allowing trial managers to focus on those participants and sites most likely experiencing COVID-19 related symptoms and impact.

With the FDA’s recently released guidance on the conduct of clinical trials for medical products during the COVID-19 pandemic, upholding the safety of trial participants, maintaining compliance and minimizing risks to trial integrity are pressing issues for sponsors to manage in their ongoing studies. elluminate COVID-19 Analytics help clinical teams comply with FDA recommendations by enabling sponsors to identify missed visits and forecast upcoming future visits, including those for dosing, which have a greater likelihood to be missed based on a variety of data sources. This allows clinical teams to identify the sites and patients that may need additional resources and support, such as remote visits and additional supplies, to help sustain ongoing participation in the study.

“We developed elluminate COVID-19 Analytics based on feedback from clients looking to expand their use of elluminate for immediate insights on the pandemic’s impact with their ongoing clinical trials,” said Raj Indupuri, CEO of eClinical Solutions. “After hearing similar needs across clients, we rapidly developed a validated, rich analytics app with smart visualizations that can be used for any trial. We are inspired by how hard the research community is working both to find a treatment for COVID-19 and to ensure critical new therapies in development continue to progress. We believe these analytics help minimize risks with trial conduct and help sponsors make better decisions during this time.”

elluminate COVID-19 Analytics are now available and complimentary for all existing elluminate clients. New clients can use them for a reduced rate. For more information on elluminate COVID-19 Analytics, eClinical Solutions is hosting a live webcast on Wednesday, April 8 at 11 am EDT/8 am PDT. Visit https://www.eclinicalsol.com/webinars/elluminate-covid-19-analytics to register.

About eClinical Solutions LLC

eClinical Solutions is a leading global provider of cloud-based enterprise software and software-driven clinical data services. The elluminate platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies. For more information, visit http://www.eclinicalsol.com.

Share article on social media or email:

Meta Special Aerospace Supports Medical Community of Oklahoma


News Image

“Support from community partners, such as Meta Special Aerospace, is monumental in helping our team of caregivers continue to serve and help those in need during the COVID-19 crisis,” says Randy Cassimus, Director of Annual Giving, SSM Health St. Anthony Foundation.

MSA donated over 4,600 nitrile gloves in multiple sizes to the foundation on Monday. These gloves will be distributed across the St. Anthony medical network.

“Meta Special Aerospace is happy to be able to give back to our community during this time of need. The caregivers and medical personnel are giving tirelessly to our community and we wanted to do all we could to support that work,” says Mike Bowen, VP Aviation Services, Meta Special Aerospace.

The medical community has been hit hard since the global outbreak of COVID-19. It’s been an incredibly stressful time for those who work on the front lines of health care. Longer hours, weeks, and limited supplies have only added to this stress. Now more than ever, it’s important for the community to come together and support the medical industry during this time of need.

“Support from community partners, such as Meta Special Aerospace, is monumental in helping our team of caregivers continue to serve and help those in need during the COVID-19 crisis,” says Randy Cassimus, Director of Annual Giving, SSM Health St. Anthony Foundation.

Learn more about Meta Special Aerospace at http://www.metaspecialaerospace.com.

Share article on social media or email:

ConsenSys Health Launches Global STOP COVID-19 Ethereum Hackathon


ConsenSys Health issued a call for hundreds of healthcare and life sciences leaders worldwide to serve as mentors, lending their industry expertise to Web3.0 technologists as they come together to develop solutions.

Today, ConsenSys Health announced the Stop COVID-19 Virtual Hackathon launching April 13 and running until May 11, 2020. The hackathon is co-sponsored by Gitcoin, Hyperledger, ConsenSys, One Million Developers, and OpenMined, leveraging blockchain and other emerging technologies to improve data access and veracity for researchers, healthcare experts, and life sciences professionals attempting to better understand and stop COVID-19 and prevent future pandemics. ConsenSys Health is seeking to accelerate the launch of operational technology as part of the fight against COVID-19, and has issued a call for hundreds of healthcare and life sciences leaders worldwide to serve as mentors, lending their industry expertise to Web3.0 technologists as they come together to develop solutions.

“In the face of the COVID-19 crisis, our goal for this global competition is to bring together healthcare and life sciences domain experts with engineers from three open source software communities: Ethereum, Hyperledger, and OpenMined. Working together for the first time with a very specific toolset, this interdisciplinary group will rapidly create highly-relevant solutions with the potential to have both immediate- and long-term positive impact,” said Heather Leigh Flannery, Founder and Chief Executive Officer of ConsenSys Health. “The core of our effort is to leverage converging innovations like blockchain, tokenization, zero-knowledge cryptography, and federated machine learning to advance immediate and long-term public health goals while preserving individual privacy.”

The STOP COVID-19 Hackathon solutions will be evaluated by each phase of the pandemic they address, leveraging the model proposed by McKinsey & Company: Resolve, Resilience, Return, Reimagination, and Reform. The healthcare and life sciences expert volunteers serving as mentors will help software developers understand key topic areas in those phases. Some of these areas include clinical trials for treatments and vaccines, global screening data, vulnerable and at-risk populations, identity provenance and consent, privacy-preserving location tracking, and supply chain optimization for ventilators and other vital medical supplies.

The Hackathon is hosted on Gitcoin, a platform for developers to collaborate and monetize their skills while working on open source projects through bounties, grants, and hackathons. Gitcoin has facilitated over 4 million dollars of value transfer for open source work within their community of 36,000 developers. For those looking to compete, the prize money for the STOP COVID-19 Hackathon totals $20,000, including $10,000 for first place, $7,000 for second place and $3,000 for third place. Winning entries will be fast-tracked for additional funding sources through Gitcoin and ConsenSys grants, as well as other funding opportunities within ConsenSys Health. For those looking to learn more about blockchain, ConsenSys Academy is offering two full weeks of training for free to novice Web 3.0 developers who want to get up to speed quickly to contribute to the hackathon. Kaleido, an industry leading enterprise blockchain platform, will be available for “Technical Tuesday” and “Walkthrough Wednesday” virtual sessions throughout the Hackathon, and ConsenSys product Infura will also have open hours with engineering every Thursday.

“To take on the challenges brought forth by COVID-19, it’s vital to marshall experts from across disciplines and markets,” said Brian Behlendorf, executive director at Hyperledger. “This Hackathon brings together the medical and scientific communities and elite developers with the singular goal of developing operational solutions, built on cutting-edge software, to mitigate damage and speed recovery from this pandemic. Hyperledger fully embraces this opportunity to help accelerate innovation on this front and will engage its community and technologies in this incredibly important work.”

Starting April 6, Hackathon participants will be able to join Q&A-based virtual panels with mentors from academia, public and private sector healthcare and life sciences organizations to better understand the problem space, as well as identify mentors as the right fit for future endorsements of projects. Close collaboration of industry mentors and software engineers ensures that the solutions generated will meet the complex requirements of the healthcare and life sciences ecosystem.

The confirmed judges for the Hackathon to date include Joseph Lubin, Founder and CEO of ConsenSys and Co-Creator of Ethereum; Brian Behlendorf, Executive Director of Hyperledger; Dr. Alex Cahana, Chief Medical Officer and EMEA Market Leader of ConsenSys Health; Dr. Sean Manion, Chief Scientific Officer of ConsenSys Health, Dr. Jonathan Holt, Chief Medical Informatics Officer of ConsenSys Health, and Debbie Bucci, Director, Patient-Mediated and Institutional Data Exchange at ConsenSys Health.

To join the STOP COVID-19 Hackathon as a mentor, partner or participant, visit ConsenSysHealth.com/COVID-19.

To learn more about the development resources and training available, register to join an introductory virtual event on Monday, April 6 at 12 EDT.

About ConsenSys Health

ConsenSys Health is a spin-off from ConsenSys, one of the world’s largest blockchain companies, focused on solving the biggest problems in healthcare. We are part of an ecosystem of technology and industry partners seeking to drive positive, inclusive change in healthcare and the life sciences. As a member of the Covid-19 Healthcare Coalition, we are committed to developing solutions to fight the current pandemic and advance the healthcare ecosystem to protect our future privacy and security. For more information, please visit http://www.ConsenSysHealth.com.

About Gitcoin

Gitcoin is a community and platform for developers to collaborate and monetize their skills while working on Open Source projects through bounties.

Share article on social media or email: